(Q42223285)

18 October 2017

Analysis of various factors on the relapse of acute neurological attacks in Behçet's disease (English)

1 reference

18 October 2017

0 references

Shunsei Hirohata

1

1 reference

18 October 2017

Hirotoshi Kikuchi

2

1 reference

18 October 2017

Tetsuji Sawada

3

1 reference

18 October 2017

Hiroko Nagafuchi

4

1 reference

18 October 2017

Masataka Kuwana

5

1 reference

18 October 2017

Mitsuhiro Takeno

6

1 reference

18 October 2017

Yoshiaki Ishigatsubo

7

1 reference

18 October 2017

language of work or name

1 reference

19 March 2014

1 reference

18 October 2017

1 reference

18 October 2017

24

1 reference

18 October 2017

6

1 reference

18 October 2017

961-965

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

18 October 2017

1 reference

Behçet's disease and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

Behçet's syndrome and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

Central nervous system symptoms in a population of Behçet's disease patients with refractory uveitis treated with cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

A double-blind trial of colchicine in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

An attack of acute neuro-Behçet's disease during the course of chronic progressive neuro-Behçet's disease: report of two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14397595.2014.891496

10.3109/14397595.2014.891496

21 January 2018

Identifiers

DOI

1 reference

18 October 2017

1 reference